Biovet Private Limited - Due diligence report

A 360° intelligence report on Biovet: trust score, financial health, credit view, compliance, directors, growth and distress signals - gener…

2005-01-27 Malur, Karnataka Active Unlisted Active Compliant
Share
BP Biovet Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Biovet — 360° Intelligence Report

Generated from MCA filings & public records
79/100
Trust Score
Low Risk

Biovet is assessed as Low Risk with a Trust Score of 79/100. Biovet is an active private limited indian non-government company incorporated in 2005, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Biovet Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
79/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
68/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.
  • Externally credit-rated (A-).

Charges position: 1 open (218.00 cr) · 1 satisfied (14.50 cr).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India1 48.0 cr
Technology Development Board1 48.0 cr
Compliance Score: 68/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 3 court forum(s).
  • 3 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
POOJA JAISWAL 01234567 Director 01/04/2018 6 yrs Approved
JALACHARI ELLA 01234567 Director 01/04/2018 6 yrs Approved
Raches Virendradev Ella 01234567 Director 01/04/2018 6 yrs Approved
SREENIVASULU KILARI 01234567 Director 01/04/2018 6 yrs Approved
Prateek Kumar Pandey 01234567 Director 01/04/2018 6 yrs Approved
Ramesh Babu Vutukuri 01234567 Director 01/04/2018 6 yrs Approved
Narayanaiah Sainath Sreenath 01234567 Director 01/04/2018 6 yrs Approved
  • 7 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2025 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
3
Capital events
4 allotment(s) · 4 transfer(s)
Group entityRelationship% held
Innova Agri Bio Park Private Limited Associate Company 74.00%
Bharat Biotech International Limited Associate Company 74.00%
Happy Reliable Surgeries Private Limited Associate Company 74.00%

Key managerial personnel: JALACHARI ELLA (Whole-time director) · SREENIVASULU KILARI (Whole-time director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 75
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 21+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
1 open charge(s) registered - assets are encumbered.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence73/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment84/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 1 open charge(s) of 218.00 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
29 Jul 2025
Director ceased
NARAYANAIAH SAINATH SREENATH
28 Feb 2025
Director appointed
Ramesh Babu Vutukuri (Cfo)
30 Jan 2025
Director appointed
Prateek Kumar Pandey (Company Secretary)
23 Nov 2024
Director appointed
Narayanaiah Sainath Sreenath (Ceo)
31 Mar 2024
Latest balance sheet
Filed with ROC
15 Sep 2023
Director appointed
POOJA JAISWAL (Company Secretary)
01 Sep 2023
Director ceased
SANTHOSH KUMAR GUNEMONI
04 Feb 2022
Director appointed
SREENIVASULU KILARI (Whole-time director)
20 Oct 2021
Director ceased
SHREE NARAYAN SINGH
15 Jun 2020
Director ceased
YOGESWARA RAO DANDA
25 Jan 2020
Director ceased
Raches Virendradev Ella
25 Oct 2019
Securities allotted
130000000 Preference Shares - 130.00 cr raised
30 Sep 2019
Director ceased
JALACHARI ELLA
07 Sep 2019
Director ceased
SRINIVAS TADEPALLY
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 4 financial year(s).
Net profit margin moved from 0.86 to 61%.
Debt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
7 active director(s) / partner(s); board looks stable and experienced.
3 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of A- from Indiarating.
EPFO-registered employer - verifiable payroll history exists.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
2 overseas direct investment(s) (ODI) on record - international footprint.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Albaugh India Private Limited U01400MH2011FTC218278 Mumbai, Maharashtra, India
Garg Agrifoods Private Limited U15122UP2010PTC042052 Puranpur, Uttar Pradesh, India
Vivek Pharmachem (India) Limited U24232RJ1990PLC005283 Jaipur, Rajasthan, India
Mohit Paper Mills L21093DL1992PLC116600 New Delhi, Delhi, India
Kesar Petroproducts L23209PN1990PLC054829 Ratnagiri, Maharashtra, India
Teesta Agro Industries L24119WB1986PLC041245 Jalpaiguri, West Bengal, India
Indo Borax & Chemicals L24100MH1980PLC023177 Mumbai, Maharashtra, India
Alufluoride L24110AP1984PLC005096 Visakhapatnam, Andhra Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Biovet before audits and certifications: compliance score 68/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Biovet: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 65/100, margin trends, ownership structure and peer set for Biovet - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 79/100, distress signals and MSME payment-delay disclosures - know whether Biovet pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Biovet - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Biovet an active company?

Biovet has MCA status “Active” with a compliance score of 68/100 (Moderate).

Is Biovet financially healthy?

Biovet has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Biovet?

Its overall Trust Score is 79/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Biovet?

See the directors and ownership sections above for board and shareholding detail. 7 active director(s) are on record.

Does Biovet have loans or charges against its assets?

1 open charge(s) are registered against its assets, and 1 earlier charge(s) stand satisfied.

Is Biovet up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 68/100 (Moderate).

Is it risky to lend to Biovet?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.